PS
UTHR icon

Principal Securities’s United Therapeutics UTHR Stock Holding History

Principal Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
910
+148
+19% +$83.4K 0.01% 1077
2026
Q1 		$452K Buy
762
+76
+11% +$37.8K 0.01% 1021
2025
Q4 		$334K Buy
686
+31
+5% +$14.4K 0.01% 1096
2025
Q3 		$275K Sell
655
-1,250
-66% -$420K ﹤0.01% 1149
2025
Q2 		$547K Sell
1,905
-269
-12% -$80.4K 0.01% 821
2025
Q1 		$767K Hold
2,174
– – 0.02% 636
2024
Q4 		$767K Buy
2,174
+270
+14% +$99.2K 0.02% 632
2024
Q3 		$682K Buy
1,904
+426
+29% +$144K 0.02% 657
2024
Q2 		$471K Buy
1,478
+566
+62% +$150K 0.01% 721
2024
Q1 		$210K Buy
912
+12
+1% +$2.71K 0.01% 996
2023
Q4 		$198K Buy
+900
New +$207K 0.01% 937

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Principal Securities's UTHR Position: Q2 2026 in Review

Principal Securities increased its United Therapeutics (UTHR) stake by 19% in Q2 2026, buying an estimated $83.4K and bringing the position to 910 shares worth $493K. The position accounts for 0.01% of the portfolio, ranked #1077.

Principal Securities first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $767K in Q1 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Principal Securities held 910 shares of United Therapeutics worth $493K as of Q2 2026.
  • Principal Securities bought 148 United Therapeutics shares in Q2 2026, an estimated $83.4K.
  • United Therapeutics made up 0.01% of Principal Securities's portfolio in Q2 2026, its #1077 holding.
  • Principal Securities first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's United Therapeutics position peaked at $767K in Q1 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.